Interferon (IFN)-beta, the most effective immunomodulatory treatment for MS
, inhibits the proliferation of myelin-specific T cells. We report that IFN
-beta moderately enhances the expression of the death receptor, CD95, at th
e surface of human antigen-specific T cells. However, T-cell apoptosis was
not induced by IFN beta-1a or IFN beta-1b as assessed by caspase activity o
r DNA fragmentation. Immunomodulation mediated by IFN-beta does not directl
y involve apoptotic pathways in human T cells.